Latest papers

Factor V deficiency: a concise review.

Prevention of haemophilic arthropathy during childhood. May common orthopaedic management be extrapolated from patients without inhibitors to patients with inhibitors?

Prevention of arthropathy: may it be extrapolated from patients without inhibitors to patients with inhibitors?

Experiences in the prevention of arthropathy in haemophila patients with inhibitors.

Synoviorthesis in haemophilia patients with inhibitors.

The role of rehabilitation and sports in haemophilia patients with inhibitors.

Clinical and echographical control protocol of haemarthrosis in haemophilia patients with inhibitors: evaluation of the efficacy of recombinant factor VIIa in the evolution process (EFFISEVEN protocol).

Articular status of haemophilia patients with inhibitors.

Orthopaedic surgery in haemophilia patients with inhibitors as the last resort.

Single-dose recombinant activated factor VII for the treatment of joint bleeds in hemophilia patients with inhibitors.

How to get rid of inhibitors.

Genetic aspects and research development in haemostasis.

New advances in the therapeutic and laboratory management of patients with haemophilia and inhibitors.

Inhibitor development.

Rare bleeding disorders.

[High-titer idiopathic acquired factor V inhibitor patient showing decreased activities of multiple coagulation factors].

Acquired factor VIII inhibitors in oncohematology: a systematic review.

Successful response to rituximab in two cases of acquired haemophilia refractory to standard-therapy.

Adjunctive role for recombinant activated factor VII in the treatment of bleeding secondary to a factor V inhibitor.

Acquired transitory factor XI inhibitor after gynaecological surgery.